Offering biomedical innovators the experience, expertise, and funding required for success.
Through the RCT Ventures program, venture capital is provided to start-up or early-stage companies with technologies that have the potential to become significant biomedical products with a definite competitive edge. Learn more ›
RCT develops and invests in technologies that enhance and enable the discovery and manufacture of therapeutics and diagnostics. Many of these life science tools are available from RCT through affordable nonexclusive licensing. Learn more ›
RCT Demonstrates a Hundred-fold Improvement in Penetration of Solid Tumors Using Therapeutic ABDURINS Compared to Antibodies. Results published in the online Journal, PLoS ONE (available here) Tucson, Arizona – August 31, 2015 – Research Corporation Technologies (RCT) and collaborators have … Learn more